A pilot retrospective study of comprehensive nursing care on psychological disorder in colorectal cancer undergoing chemotherapy

Article Oncology

Adjuvant Therapy for Stage II Colon Cancer: ASCO Guideline Update

Nancy N. Baxter et al.

Summary: The study aims to develop recommendations for adjuvant therapy for patients with resected stage II colon cancer.

JOURNAL OF CLINICAL ONCOLOGY (2022)

Add to Collection

Article Surgery

Factors affecting short-term survival in patients older than 85 treated with resection for stage II and III colon cancer

Gabriela Poles et al.

Summary: Patients aged 85 and older have a high incidence of colon cancer and poor prognosis. Factors associated with 90-day mortality in this population include nonelective surgery, preoperative weight loss, and multiple comorbidities, while minimally invasive surgery is associated with lower mortality rates.

SURGERY (2022)

Add to Collection

Article Multidisciplinary Sciences

Survival benefit with adjuvant chemotherapy in stage III microsatellite-high/deficient mismatch repair colon cancer: a systematic review and meta-analysis

Gianluca Tomasello et al.

Summary: In patients with stage III MSI-H/dMMR CRC, adjuvant chemotherapy is associated with a significant improvement in overall survival (OS), but does not significantly impact disease-free survival (DFS). This suggests that MSI-H/dMMR status is a predictive factor for benefit from postoperative chemotherapy in stage III CRC.

SCIENTIFIC REPORTS (2022)

Add to Collection

Review Pharmacology & Pharmacy

Chemotherapy in resectable or potentially resectable colon cancer with liver metastases

Zarka Samoon et al.

Summary: The treatment of colorectal cancer liver metastases still faces many challenges, including determining the optimal treatment combination, duration, sequence, role of biologic agents, and timing of surgical resection. Further research is needed, especially in patients with resectable or borderline liver metastases, to determine the best adjuvant therapy options.

EXPERT OPINION ON PHARMACOTHERAPY (2022)

Add to Collection

Article Medicine, General & Internal

Clinical implication of adjuvant chemotherapy according to mismatch repair status in patients with intermediate-risk stage II colon cancer: a retrospective study

Byung Woog Kang et al.

Summary: This study found that the use of adjuvant chemotherapy was correlated with better disease-free survival in intermediate-risk stage II colon cancer patients identified as MSI-L/MSS or pMMR.

JOURNAL OF YEUNGNAM MEDICAL SCIENCE (2022)

Add to Collection

Article Oncology

Optimal adjuvant chemotherapy completion time for stage III colon cancer: a cohort study

Jing-Qing Ren et al.

Summary: The completion time of adjuvant chemotherapy is related to the 3-year disease-free survival of stage III colon cancer patients, with a cut-off time of 28 weeks. Those who completed adjuvant chemotherapy >28 weeks had a higher risk of 3-year recurrence.

JOURNAL OF GASTROINTESTINAL ONCOLOGY (2021)

Add to Collection

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Add to Collection

Editorial Material Gastroenterology & Hepatology